Current Ratio of Compass Therapeutics, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Compass Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Dec 2018 to 30 Sep 2025.
Compass Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 1167%, a 51% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Change (%)

Compass Therapeutics, Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	1167%	-1201%	-51%	30 Sep 2025
Q2 2025	1199%	-887%	-43%	30 Jun 2025
Q1 2025	1463%	-682%	-32%	31 Mar 2025
Q4 2024	2194%	+398%	+22%	31 Dec 2024
Q3 2024	2369%	+809%	+52%	30 Sep 2024
Q2 2024	2086%	+636%	+44%	30 Jun 2024
Q1 2024	2144%	+815%	+61%	31 Mar 2024
Q4 2023	1797%	+508%	+39%	31 Dec 2023
Q3 2023	1560%	+213%	+16%	30 Sep 2023
Q2 2023	1450%	+281%	+24%	30 Jun 2023
Q1 2023	1329%	+356%	+37%	31 Mar 2023
Q4 2022	1288%	+618%	+92%	31 Dec 2022
Q3 2022	1347%	+928%	+222%	30 Sep 2022
Q2 2022	1169%	+697%	+148%	30 Jun 2022
Q1 2022	972%	+459%	+89%	31 Mar 2022
Q4 2021	671%	+114%	+20%	31 Dec 2021
Q3 2021	419%	-66%	-14%	30 Sep 2021
Q2 2021	472%	+40%	+9.2%	30 Jun 2021
Q1 2021	514%	+254%		31 Mar 2021
Q4 2020	557%	+296%	+114%	31 Dec 2020
Q3 2020	485%	+480%		30 Sep 2020
Q2 2020	432%	+426%		30 Jun 2020
Q1 2020	260%^*	+252%		31 Mar 2020
Q4 2019	261%	+254%		31 Dec 2019
Q3 2019	4.8%^*			30 Sep 2019
Q2 2019	6%^*			30 Jun 2019
Q1 2019	7.8%^*			31 Mar 2019
Q4 2018	7%^*			31 Dec 2018

* An asterisk sign (*) next to the value indicates that the value is likely invalid.